Sanofi-Aventis Fights Off Plavix Patent Challenge In Canada
Canada's Federal Court issued the ruling late Monday, rejecting Apotex's challenge to the Plavix patent and holding that the asserted claims are novel, not obvious and infringed.
Apotex said it planned to appeal the case.
The decision, after a trial that ran from Feb. 21 to Feb. 25, came earlier than expected, about a month ahead of the April...
To view the full article, register now.